SCHEMBL6513748

SCHEMBL6513748

C=CCn1c(-c2cccc(Cl)c2[N+](=O)[O-])nc2cccc(C)c21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
LMNA P02545 3/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 1/20 0.40
GFER P55789 2/20 0.38
CFTR P13569 1/20 0.37
NPSR1 Q6W5P4 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
IRAK4 Q9NWZ3 1/20 0.35
APOBEC3G Q9HC16 1/20 0.34
GAA P10253 1/20 0.34
RECQL P46063 1/20 0.34
BRD4 O60885 1/20 0.34
CASR P41180 1/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
CRHBP P24387 1/20 0.33
KMT2A Q03164 1/20 0.33
CRHR2 Q13324 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6518506 0.85 CFTR (0.49) ALDH1A1LMNAKDM4EHPGDGFER
SCHEMBL6520247 0.83 ALDH1A1 (0.40) ALDH1A1LMNAKDM4EHPGDGFER
SCHEMBL29077097 0.71 ALDH1A1 (0.57) ALDH1A1LMNAKDM4EHPGDNPSR1
SCHEMBL30581234 0.71 ALDH1A1 (0.57) ALDH1A1LMNAKDM4EHPGDNPSR1
SCHEMBL6515682 0.67 ATM (0.53) ALDH1A1LMNAKDM4ECFTRNPSR1
SCHEMBL6514222 0.67 ALDH1A1 (0.59) ALDH1A1LMNAKDM4EHPGDGFER
SCHEMBL30581249 0.67 KDM4E (0.60) ALDH1A1LMNAKDM4EHPGDNPSR1
SCHEMBL29076186 0.67 KDM4E (0.60) ALDH1A1LMNAKDM4EHPGDNPSR1
SCHEMBL6512290 0.66 ATM (0.40) ALDH1A1TDP1
SCHEMBL541489 0.66 TDP1 (0.72) ALDH1A1HPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050239767-A1 Intermolecular SNAr of the heterocycle-activated nitro and fluoro groups-application in the synthesis of polyazamacrocyclic ligands NATIONAL SCIENCE FOUNDATION 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239767-A1 Intermolecular SNAr of the heterocycle-activated nitro and fluoro groups-application in the synthesis of polyazamacrocyclic ligands TECR, PAICS, DCXR ALDH1A1 1812/4885LMNA 1745/4885KDM4E 1602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.